Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
177 | AGER | advanced glycosylation end-product specific receptor | |
335 | APOA1 | apolipoprotein A1 | |
355 | FAS | Fas cell surface death receptor | |
639 | PRDM1 | PR/SET domain 1 | |
712 | C1QA | complement C1q A chain | |
717 | C2 | complement C2 | |
718 | C3 | complement C3 | |
720 | C4A | complement C4A (Chido/Rodgers blood group) | |
721 | C4B | complement C4B (Chido/Rodgers blood group) | |
831 | CAST | calpastatin |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
23853 | Def6 | differentially expressed in FDCP 6 | |
27056 | Irf5 | interferon regulatory factor 5 | |
27221 | Chaf1a | chromatin assembly factor 1, subunit A | |
53791 | Tlr5 | toll-like receptor 5 | |
60504 | Il21r | interleukin 21 receptor | |
60505 | Il21 | interleukin 21 | |
66724 | Tab3 | TGF-beta activated kinase 1/MAP3K7 binding protein 3 | |
67332 | Snrpd3 | small nuclear ribonucleoprotein D3 | |
68652 | Tab2 | TGF-beta activated kinase 1/MAP3K7 binding protein 2 | |
70839 | P2ry12 | purinergic receptor P2Y, G-protein coupled 12 |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
24232 | C3 | complement C3 | |
24233 | C4a | complement C4A | |
24296 | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 | |
24699 | Ptprc | protein tyrosine phosphatase, receptor type, C | |
24770 | Ccl2 | C-C motif chemokine ligand 2 | |
24787 | Sod2 | superoxide dismutase 2 | |
24835 | Tnf | tumor necrosis factor | |
24854 | Clu | clusterin | |
25149 | Esr2 | estrogen receptor 2 | |
25325 | Il10 | interleukin 10 |
Gene ID | Gene Symbol | Description | Source | Organism |
---|---|---|---|---|
373644 | ldlr.S | low density lipoprotein receptor S homeolog | Xenopus laevis (African clawed frog) | |
397757 | ldlr.L | low density lipoprotein receptor L homeolog | Xenopus laevis (African clawed frog) | |
734211 | epor.L | erythropoietin receptor L homeolog | Xenopus laevis (African clawed frog) |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
174116 | gldi-2 | EGF-like domain-containing protein | |
177044 | smf-3 | NRAMP-like transporter smf-3 | |
178748 | zmp-3 | Matrix metalloproteinase-C | |
179105 | F09G2.8 | putative phospholipase D F09G2.8 | |
179632 | aman-2 | Alpha-mannosidase | |
180836 | W01C8.5 | DM13 domain-containing protein | |
180939 | smf-1 | NRAMP-like transporter smf-1 | |
191766 | smf-2 | NRAMP-like transporter smf-2 | |
3565419 | clr-1 | Receptor-type tyrosine-protein phosphatase;protein-tyrosine-phosphatase |
HPO ID | HPO Term |
---|---|
HP:0002039 | Anorexia |
HP:0001250 | Seizure |
HP:0012378 | Fatigue |
HP:0000716 | Depression |
HP:0003493 | Antinuclear antibody positivity |
HP:0001873 | Thrombocytopenia |
HP:0000155 | Oral ulcer |
HP:0001882 | Leukopenia |
HP:0007417 | Discoid lupus rash |
HP:0000822 | Hypertension |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024